These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38352311)

  • 1. Evidence of artemisinin partial resistance in North-western Tanzania: clinical and drug resistance markers study.
    Ishengoma DS; Mandara CI; Bakari C; Fola AA; Madebe RA; Seth MD; Francis F; Buguzi C; Moshi R; Garimo I; Lazaro S; Lusasi A; Aaron S; Chacky F; Mohamed A; Njau RJA; Kitau J; Rasmussen C; Bailey JA; Juliano JJ; Warsame M
    medRxiv; 2024 Feb; ():. PubMed ID: 38352311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of artemisinin partial resistance in northwestern Tanzania: clinical and molecular markers of resistance.
    Ishengoma DS; Mandara CI; Bakari C; Fola AA; Madebe RA; Seth MD; Francis F; Buguzi CC; Moshi R; Garimo I; Lazaro S; Lusasi A; Aaron S; Chacky F; Mohamed A; Njau RJA; Kitau J; Rasmussen C; Bailey JA; Juliano JJ; Warsame M
    Lancet Infect Dis; 2024 Aug; ():. PubMed ID: 39159633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic efficacy of artesunate-amodiaquine and artemether-lumefantrine and polymorphism in Plasmodium falciparum kelch13-propeller gene in Equatorial Guinea.
    Riloha Rivas M; Warsame M; Mbá Andeme R; Nsue Esidang S; Ncogo PR; Phiri WP; Oki Eburi C; Edú Maye CE; Menard D; Legrand E; Berzosa P; Garcia L; Lao Seoane AK; Ntabangana SC; Ringwald P
    Malar J; 2021 Jun; 20(1):275. PubMed ID: 34158055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Liberia: in vivo efficacy and frequency of molecular markers.
    Koko VS; Warsame M; Vonhm B; Jeuronlon MK; Menard D; Ma L; Taweh F; Tehmeh L; Nyansaiye P; Pratt OJ; Parwon S; Kamara P; Asinya M; Kollie A; Ringwald P
    Malar J; 2022 Apr; 21(1):134. PubMed ID: 35477399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of artemisinin-based combination therapy, and molecular markers for artemisinin and piperaquine resistance in Mainland Tanzania.
    Kakolwa MA; Mahende MK; Ishengoma DS; Mandara CI; Ngasala B; Kamugisha E; Kataraihya JB; Mandike R; Mkude S; Chacky F; Njau R; Premji Z; Lemnge MM; Warsame M; Menard D; Kabanywanyi AM
    Malar J; 2018 Oct; 17(1):369. PubMed ID: 30333022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High cure rates and tolerability of artesunate-amodiaquine and dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Kibaha and Kigoma, Tanzania.
    Mandara CI; Francis F; Chiduo MG; Ngasala B; Mandike R; Mkude S; Chacky F; Molteni F; Njau R; Mohamed A; Warsame M; Ishengoma DS
    Malar J; 2019 Mar; 18(1):99. PubMed ID: 30909922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic efficacy trial of artemisinin-based combination therapy for the treatment of uncomplicated malaria and investigation of mutations in k13 propeller domain in Togo, 2012-2013.
    Dorkenoo AM; Yehadji D; Agbo YM; Layibo Y; Agbeko F; Adjeloh P; Yakpa K; Sossou E; Awokou F; Ringwald P
    Malar J; 2016 Jun; 15():331. PubMed ID: 27334876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of mutations associated with artemisinin partial resistance and sulfadoxine-pyrimethamine resistance in 13 regions in Tanzania in 2021: a cross-sectional survey.
    Juliano JJ; Giesbrecht DJ; Simkin A; Fola AA; Lyimo BM; Pereus D; Bakari C; Madebe RA; Seth MD; Mandara CI; Popkin-Hall ZR; Moshi R; Mbwambo RB; Niaré K; MacInnis B; Francis F; Mbwambo D; Garimo I; Chacky F; Aaron S; Lusasi A; Molteni F; Njau RJA; Nhiga SL; Mohamed A; Bailey JA; Ishengoma DS
    Lancet Microbe; 2024 Oct; 5(10):100920. PubMed ID: 39159629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali, 2015-2016.
    Diarra Y; Koné O; Sangaré L; Doumbia L; Haidara DBB; Diallo M; Maiga A; Sango HA; Sidibé H; Mihigo J; Nace D; Ljolje D; Talundzic E; Udhayakumar V; Eckert E; Woodfill CJ; Moriarty LF; Lim P; Krogstad DJ; Halsey ES; Lucchi NW; Koita OA
    Malar J; 2021 May; 20(1):235. PubMed ID: 34034754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017.
    Davlantes E; Dimbu PR; Ferreira CM; Florinda Joao M; Pode D; Félix J; Sanhangala E; Andrade BN; Dos Santos Souza S; Talundzic E; Udhayakumar V; Owens C; Mbounga E; Wiesner L; Halsey ES; Martins JF; Fortes F; Plucinski MM
    Malar J; 2018 Apr; 17(1):144. PubMed ID: 29615039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic efficacy of artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Chad: clinical and genetic surveillance.
    Issa MS; Warsame M; Mahamat MHT; Saleh IDM; Boulotigam K; Djimrassengar H; Issa AH; Abdelkader O; Hassoumi M; Djimadoum M; Doderer-Lang C; Ndihiokubwayo JB; Rasmussen C; Menard D
    Malar J; 2023 Aug; 22(1):240. PubMed ID: 37612601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania.
    Mårtensson A; Strömberg J; Sisowath C; Msellem MI; Gil JP; Montgomery SM; Olliaro P; Ali AS; Björkman A
    Clin Infect Dis; 2005 Oct; 41(8):1079-86. PubMed ID: 16163624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in mainland Tanzania, 2019.
    Ngasala BE; Chiduo MG; Mmbando BP; Francis FT; Bushukatale S; Makene T; Mandara CI; Ishengoma DS; Kamugisha E; Ahmed M; Mahende MK; Kavishe RA; Muro F; Molteni F; Reaves E; Kitojo C; Greer G; Nyinondi S; Kabula B; Lalji S; Chacky F; Njau RJ; Warsame M; Mohamed A
    Malar J; 2024 Apr; 23(1):101. PubMed ID: 38594679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of artesunate-amodiaquine and artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria in Madagascar, 2018.
    Dentinger CM; Rakotomanga TA; Rakotondrandriana A; Rakotoarisoa A; Rason MA; Moriarty LF; Steinhardt LC; Kapesa L; Razafindrakoto J; Svigel SS; Lucchi NW; Udhayakumar V; Halsey ES; Ratsimbasoa CA
    Malar J; 2021 Nov; 20(1):432. PubMed ID: 34732201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of malaria among febrile patients and assessment of efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated malaria in Dolisie, Republic of the Congo.
    Pembet Singana B; Casimiro PN; Matondo Diassivi B; Kobawila SC; Youndouka JM; Basco LK; Ringwald P; Briolant S; Ndounga M
    Malar J; 2022 May; 21(1):137. PubMed ID: 35501861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in mainland Tanzania, 2018.
    Ngasala B; Chiduo MG; Bushukatale S; Mmbando BP; Makene T; Kamugisha E; Ahmed M; Mandara CI; Francis F; Mahende MK; Kavishe RA; Muro F; Ishengoma DS; Mandike R; Molteni F; Chacky F; Kitojo C; Greer G; Bishanga D; Chadewa J; Njau R; Warsame M; Kabula B; Nyinondi SS; Reaves E; Mohamed A
    Malar J; 2024 Apr; 23(1):95. PubMed ID: 38582830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends of Plasmodium falciparum molecular markers associated with resistance to artemisinins and reduced susceptibility to lumefantrine in Mainland Tanzania from 2016 to 2021.
    Bakari C; Mandara CI; Madebe RA; Seth MD; Ngasala B; Kamugisha E; Ahmed M; Francis F; Bushukatale S; Chiduo M; Makene T; Kabanywanyi AM; Mahende MK; Kavishe RA; Muro F; Mkude S; Mandike R; Molteni F; Chacky F; Bishanga DR; Njau RJA; Warsame M; Kabula B; Nyinondi SS; Lucchi NW; Talundzic E; Venkatesan M; Moriarty LF; Serbantez N; Kitojo C; Reaves EJ; Halsey ES; Mohamed A; Udhayakumar V; Ishengoma DS
    Malar J; 2024 Mar; 23(1):71. PubMed ID: 38461239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria and prevalence of Pfk13 and Pfmdr1 polymorphisms after a decade of using artemisinin-based combination therapy in mainland Tanzania.
    Ishengoma DS; Mandara CI; Francis F; Talundzic E; Lucchi NW; Ngasala B; Kabanywanyi AM; Mahende MK; Kamugisha E; Kavishe RA; Muro F; Mohamed A; Mandike R; Mkude S; Chacky F; Paxton L; Greer G; Kitojo CA; Njau R; Martin T; Venkatesan M; Warsame M; Halsey ES; Udhayakumar V
    Malar J; 2019 Mar; 18(1):88. PubMed ID: 30898164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of artesunate-amodiaquine and artemether-lumefantrine and prevalence of molecular markers associated with resistance, Guinea: an open-label two-arm randomised controlled trial.
    Beavogui AH; Camara A; Delamou A; Diallo MS; Doumbouya A; Kourouma K; Bouedouno P; Guilavogui T; Dos Santos Souza S; Kelley J; Talundzic E; Fofana A; Plucinski MM
    Malar J; 2020 Jun; 19(1):223. PubMed ID: 32580771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, multicentre assessment of the efficacy and safety of ASAQ--a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria.
    Ndiaye JL; Randrianarivelojosia M; Sagara I; Brasseur P; Ndiaye I; Faye B; Randrianasolo L; Ratsimbasoa A; Forlemu D; Moor VA; Traore A; Dicko Y; Dara N; Lameyre V; Diallo M; Djimde A; Same-Ekobo A; Gaye O
    Malar J; 2009 Jun; 8():125. PubMed ID: 19505304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.